private:carthonacapital
|
3659659
|
May 23rd, 2019 12:00AM
|
Carthona Capital
|
277
|
8.00
|
Open
|
Venture Capital & Private Equity
|
May 23rd, 2019 11:38AM
|
May 23rd, 2019 11:38AM
|
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Carthona Capital was founded in 2014 when a group of like-minded venture investors came together to invest on a deal-by-deal basis. In 2017, Carthona Capital shifted to a more traditional venture capital model by raising its first fund from a mix of Institutional (Superannuation), Family Office and High Net-worth investors.
Carthona Capital likes to invest very early - their initial investment into a business is usually at the Pre-Seed, Seed, or Series A stages. Carthona then likes to follow-on strongly and continue to deploy larger amounts of capital as the business matures, and in one instance supporting a business by participating in seven different independent financing rounds.
|
Open
|
Venture Capital
|
Open
|
Level 26, 1 O'Connell St
|
Sydney
|
New South Wales
|
AU
|
2000
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Mar 18th, 2018 12:00AM
|
Carthona Capital
|
160
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Mar 18th, 2018 02:21PM
|
Mar 18th, 2018 02:21PM
|
|
Open
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 17th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 16th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 15th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 14th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 13th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 12th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 11th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|
private:carthonacapital
|
3659659
|
Feb 10th, 2018 12:00AM
|
Carthona Capital
|
134
|
7.00
|
Open
|
Venture Capital & Private Equity
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Carthona Capital is Australia’s most active seed and early stage venture investor.
The firm is largely sector agnostic and invests using its own capital in collaboration with super funds, high net worths, family offices and institutions. Carthona is a high conviction investor – typically selecting a small number of the hundreds of deals examined each year, and focusing its resources – capital, advice, mentorship, learnings, network etc. to partner with management to build successful businesses.
Our Partners share a long history of successfully investing in early-stage businesses, and their common approach and philosophy to investing brought them together at Carthona Capital.
|
|
|
|
|
|
|
|
|
|
Carthona Capital
|
|
Pharmaceuticals & Biotechnology
|